Naveen Pemmaraju and Musa Yilmaz
Jun 17, 2025, 14:20
Naveen Pemmaraju Highlighted Musa Yilmaz’s EHA 2025 Presentation on DEC/VEN/QUIZ in FLT3-ITD AML
Naveen Pemmaraju, Professor at the Department of Leukemia of MD Anderson Cancer Center, shared a post on X:
“EHA 2025 Wonderful job, oral presentation at European Hematology Association by our own Musa Yilmaz, MD Anderson Cancer Center on DEC/VEN/QUIZ combination for patients with FLT3ITD AML.”
More posts on Hemostasis Today.
-
Feb 16, 2026, 15:44Lakmali Silva: Silva Lab Showcases Research at the Gordon Research Conference on Plasminogen and Extracellular Proteolysis
-
Feb 16, 2026, 15:36Heghine Khachatryan: Strengthening Maternal Resilience Against Postpartum Hemorrhage
-
Feb 16, 2026, 15:34Sevak Mirabyan: Advancing Cancer Care Through Knowledge, Collaboration, and Early Diagnosis in Armenia
-
Feb 16, 2026, 15:29Chokri Ben Lamine: Key Clinical Insights of Drug Induced Thrombocytopenia
-
Feb 16, 2026, 15:28Ney Carter Borges: Coronary Intravascular Lithotripsy – Clinical Performance and Safety
-
Feb 16, 2026, 15:24Flora Peyvandi: Highlighting Overdose, Homicide, and Suicide as Causes of Maternal Death in the US
-
Feb 16, 2026, 14:53Wafaa Abougabal: Differential Diagnosis of Acute Neurologic Deficits and Stroke in PICU
-
Feb 16, 2026, 14:49Nayab Ahmed: Synthesis of ATP and Its Significance in Storage of Blood
-
Feb 16, 2026, 14:44Lukasz Kuzma: NOAC Monotherapy vs NOAC Plus Clopidogrel in AF Beyond One Year After DES